immune checkpoint blockade therapy Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

Philogen S.p.A. (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadnon-small cell lung cancer

I am/have/hadmsi-h

I am/have/hadoophorectomy

I am/have/hadpet/ct

I am/have/hadsolid tumour

I am/have/hadhormonal contraception

I am/have/hadalopecia

I am/have/hadlarge b-cell lymphoma

I am/have/hadcarcinoma

I am/have/hadcancer, hepatocellular

I am/have/hadhair thinning

I am/have/hadmetastatic colorectal cancer

I am/have/hadanti-hbs

I am/have/hadsquamous cell carcinoma

I am/have/hadhypophysitis

I am/have/hadcervical cancer

I am/have/hadmaintenance therapy

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadhysterectomy

I am/have/hadgastric cancer

added new label for I am/have/had

more

I am looking for

I am looking forhepatitis b core antibody

I am looking forprogesterone

I am looking forblockade

I am looking forlevothyroxine

I am looking forprednisone

I am looking forestrogen

I am looking forhepatitis b surface antigen

I am looking formelanoma

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Multi-country trial
Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Recruiting

Safety and Early Signs of Efficacy of IL12-L19L19.

The purpose of this study is to describe the safety, tolerability and early signs of efficacy of the antibody-cytokine fusion protein IL12-L19L19 in patients with advanced or metastatic solid carcinomas and diffuse large B-cell lymphoma (DLBCL), after previous immune checkpoint blockade therapy. The primary objective of the study is to …

non-small cell lung cancer

msi-h

oophorectomy

pet/ct

solid tumour

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.